Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methotrexate, Blood Pressure and Arterial Function in Rheumatoid Arthritis

NCT03254589 is registered in ClinicalTrials.gov with Flinders University as lead sponsor.

NCT NCT03254589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03254589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methotrexate, Blood Pressure and Arterial Function in Rheumatoid Arthritis
Lead sponsor
Flinders University
Phase
Phase 4
Overall status
Completed
Start date
October 1, 2017
Completion date
December 31, 2023
Enrollment
124 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular risk factor, endothelial dysfunction, rheumatoid arthritis, stiffness, aortic